New York, NY - Pfizer is hoping to sell atorvastatin (Lipitor) to consumers over the counter (OTC) as a way to offset the expected plunge in revenue as the world's best-selling prescription drug goes off patent in November, according to the Wall Street Journal.
=============================
Read full article here.
0 comments:
Post a Comment
I appreciate appropriate comments but reserve the right to publish those with real credible information to contribute.